| 参附注射液治疗围产期心肌病 |
| |
| 引用本文： | 杨娟,杨绍田,程国梅.参附注射液治疗围产期心肌病[J].中国实验方剂学杂志,2012,18(2):219-221. |
| |
| 作者姓名： | 杨娟 杨绍田 程国梅 |
| |
| 作者单位： | 1. 黄河科技学院医学院,郑州,450006
2. 河南省妇幼保健院,郑州,450006 |
| |
| 摘 要： | 目的:探讨参附注射液(SFI)治疗围产期心肌病(PPCM)的临床疗效和安全性.方法:将符合PPCM诊断标准的患者抽签分为治疗组和对照组,2组均给予吸氧,利尿保钾、扩张血管、营养心肌、同时服用阿司匹林预防血栓形成、必要时应用小剂量洋地黄治疗心衰等常规治疗,孕妇适时终止妊娠.治疗组在对照组治疗的基础上加用SFI50～80 mL加入5％葡萄糖注射液250 mL,缓慢静脉滴入,每日1次,2周为1个疗程..观察比较2组相关检验、心电图、心脏超声、治疗前后的变化.结果:治疗组总有效率93.33％；对照组总有效率82.14％；两组临床疗效差异有显著性(P＜0.05).结论:SF治疗PPCM,缩短了病程,临床效果显著,无毒副反应,对孕产妇及新生儿是安全的.
|
| 关 键 词： | 围产期心肌病 中医治疗法 参附注射液 |
| 收稿时间： | 2011/8/22 0:00:00 |
Clinic Observation on Treatment of Peripartum Cardiomyopathy by Shenfu Injection |
| |
| YANG Juan,YANG Shao-tian and CHENG Guo-mei.Clinic Observation on Treatment of Peripartum Cardiomyopathy by Shenfu Injection[J].China Journal of Experimental Traditional Medical Formulae,2012,18(2):219-221. |
| |
| Authors: | YANG Juan YANG Shao-tian and CHENG Guo-mei |
| |
| Institution: | Medical School of Huanghe Science and Technology College, Zhengzhou 450006,China;Medical School of Huanghe Science and Technology College, Zhengzhou 450006,China;Henan Maternal and Child Health Hospital, Zhengzhou 450006,China |
| |
| Abstract: | Objective: Study the clinical efficacy and safety of Shenfu injection (SFI) in treatment of peripartum cardiomyopathy (PPCM). Method: The patients meeting diagnostic criteria for PPCM were divided into treatment and control groups, then the change of the related examination, ECG and echocardiography in the two groups were observed before and after treatment. Result: The total effective rate of treatment group and control group was 93.33% and 82.14%, respectively. The statistical difference between the two groups was significant (P<0.05). Conclusion: SFI can improve clinical efficacy of treatment on PPCM with a shortened course of disease. |
| |
| Keywords: | peripartum cardiomyopathy Chinese therapy Shenfu injection |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《中国实验方剂学杂志》浏览原始摘要信息 |
| 点击此处可从《中国实验方剂学杂志》下载免费的PDF全文 |
|
